RESÚMENES ENERO 2006

.

Mood - Anxiety Disorders & Antidepressants – Mood Stabilizers

(Haga un click en la información del journal para acceder al resúmen)

 

Effect of low-frequency transcranial magnetic stimulation on an affective go/no-go task in patients with major depression: Role of stimulation site and depression severity

Felix Bermpohl, Felipe Fregni, Paulo S. Boggio, Gregor Thut, Georg Northoff, Patricia T.M. Otachi, Sergio P. Rigonatti, Marco A. Marcolin and Alvaro Pascual-Leone

Psychiatry Research. Volume 141, Issue 1, 30 January 2006, Pages 1-13

 

Treatment of depression with atypical features: A meta-analytic approach

Verena Henkel, Roland Mergl, Antje-Kathrin Allgaier, Ralph Kohnen, Hans-Jürgen Möller and Ulrich Hegerl

Psychiatry Research. Volume 141, Issue 1, 30 January 2006, Pages 89-101

 

A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): Therapeutic and cognitive effect in medication free unipolar depression during 4 weeks

Dominique Januel, Gilles Dumortier, Claire-Marie Verdon, Laurence Stamatiadis, Ghassen Saba, Wanda Cabaret, René Benadhira, Jean-François Rocamora, Sonia Braha, Khalid Kalalou, Pr Eric Vicaut and J. Fermanian

Progress in Neuro-Psychopharmacology and Biological Psychiatry. Volume 30, Issue 1, January 2006, Pages 126-130

 

Effect of treatment on serum brain–derived neurotrophic factor levels in depressed patients

A. Saffet Gonul, F. Akdeniz, F. Taneli, O. Donat, Ç. Eker and S. Vahip

European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 6: 381 - 386

 

 

Is dose escalation of antidepressants a rational strategy after a medium–dose treatment has failed? A systematic review

M. Adli, Ch. Baethge, A. Heinz, N. Langlitz and M. Bauer

European Archives of Psychiatry and Clinical Neuroscience 2005; Volume 255, Number 6: 387 - 400

 

 

 

Stress and depression-induced immune dysfunction: Implications for the development and progression of cancer

International Review of Psychiatry. Volume 17, Number 6 / 04 January 2006:515 - 527

 

Antidepressants suppress production of the Th(1) cytokine interferon-gamma, independent of monoamine transporter blockade
Diamond M, Kelly JP, Connor TJ

Eur Neuropsychopharmacol. 2005 Dec 30; [Epub ahead of print]

 

A possible association between the [minus sign]116C/G single nucleotide polymorphism of the XBP1 gene and lithium prophylaxis in bipolar disorder

Takuya Masui, Ryota Hashimoto, Ichiro Kusumi, Katsuji Suzuki, Teruaki Tanaka, Shin Nakagawa, Hiroshi Kunugi and Tsukasa Koyama

The International Journal of Neuropsychopharmacology (2006), 9: 83-88

 

Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive–compulsive disorder (OCD) and Tourette's syndrome (TS)

Antonio Mantovani, Sarah H. Lisanby, Fulvio Pieraccini, Monica Ulivelli, Paolo Castrogiovanni and Simone Rossi 

The International Journal of Neuropsychopharmacology (2006), 9: 95-100

 

Comorbidity of Major Depression and Migraine— A Canadian Population-Based Study

Carmen V Molgat, Scott B Patten

Can J Psychiatry 2005;50:832–837

 

Effects of lithium on saccadic eye movements in healthy subjects in a ten-day double-blind placebo-controlled cross-over pilot study
Amado I, Galinowski A, Daban C, Ramdane-Cherif Z, Poirier E, Bourdel MC, Poirier MF, Krebs MO

Pharmacopsychiatry. 2005 Nov;38(6):321-5

Executive function improvement upon remission of recurrent unipolar depression
Biringer E, Lundervold A, Stordal K, Mykletun A, Egeland J, Bottlender R, Lund A

Eur Arch Psychiatry Clin Neurosci. 2005 Dec;255(6):373-80

A randomized, controlled trial of sequential bilateral repetitive transcranial magnetic stimulation for treatment-resistant depression
Fitzgerald PB, Benitez J, de Castella A, Daskalakis ZJ, Brown TL, Kulkarni J

Am J Psychiatry. 2006 Jan;163(1):88-94

A Swedish national twin study of lifetime major depression
Kendler KS, Gatz M, Gardner CO, Pedersen NL

Am J Psychiatry. 2006 Jan;163(1):109-14

Antidepressants in Amniotic Fluid: Another Route of Fetal Exposure
Loughhead AM, Fisher AD, Newport DJ, Ritchie JC, Owens MJ, Devane CL, Stowe ZN

Am J Psychiatry. 2006 Jan;163(1):145-147

Continuity of antidepressant treatment for adults with depression in the United States
Olfson M, Marcus SC, Tedeschi M, Wan GJ

Am J Psychiatry. 2006 Jan;163(1):101-8

Efficacy and tolerability of vardenafil in men with mild depression and erectile dysfunction: the depression-related improvement with vardenafil for erectile response study
Rosen R, Shabsigh R, Berber M, Assalian P, Menza M, Rodriguez-Vela L, Porto R, Bangerter K, Seger M, Montorsi F

Am J Psychiatry. 2006 Jan;163(1):79-87

Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M

Am J Psychiatry. 2006 Jan;163(1):28-40

Premenstrual symptoms and perimenopausal depression
Richards M, Rubinow DR, Daly RC, Schmidt PJ

Am J Psychiatry. 2006 Jan;163(1):133-7

Psychomotor slowing as a predictor of fluoxetine nonresponse in depressed outpatients
Taylor BP, Bruder GE, Stewart JW, McGrath PJ, Halperin J, Ehrlichman H, Quitkin FM

Am J Psychiatry. 2006 Jan;163(1):73-8

Six months of treatment for depression: outcome and predictors of the course of illness
Mulder RT, Joyce PR, Frampton CM, Luty SE, Sullivan PF

Am J Psychiatry. 2006 Jan;163(1):95-100

Suicide risk during antidepressant treatment
Simon GE, Savarino J, Operskalski B, Wang PS

Am J Psychiatry. 2006 Jan;163(1):41-7

Toward a comprehensive developmental model for major depression in men
Kendler KS, Gardner CO, Prescott CA

Am J Psychiatry. 2006 Jan;163(1):115-24

 

Nick C Patel, Melissa P DelBello and Stephen M Strakowski

Bipolar Disorders. Volume 8 Page 95  - February 2006

A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania

A. Eden Evins, Christina Demopulos, Andrew Nierenberg, Melissa A. Culhane, Lori Eisner and Gary Sachs

Bipolar Disorders. Volume 8 Page 75  - February 2006

Diagnostic subtypes of bipolar disorder in older versus younger adults

Lars Vedel Kessing

Bipolar Disorders. Volume 8 Page 56  - February 2006

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

Stuart F Kushner, Akbar Khan, Rosanne Lane and William H Olson

Bipolar Disorders. Volume 8 Page 15  - February 2006

Affective instability as rapid cycling: theoretical and clinical implications for borderline personality and bipolar spectrum disorders

Dean F MacKinnon and Ronald Pies

Bipolar Disorders. Volume 8 Page 1  - February 2006

 

Exploratory study of premenstrual symptoms and serotonin variability

A. H. Clayton, A. E. Keller, C. Leslie and W. Evans

Archives of Women's Mental Health 2006; Volume 9, Number 1: 51 - 57

Pulse-Loaded Intravenous Clomipramine in Treatment-Resistant Obsessive-Compulsive Disorder
Koran, Lorrin M.; Aboujaoude, Elias; Ward, Herbert; Shapira, Nathan A.; Sallee, Floyd R.; Gamel, Nona; Elliott, Michael

Journal of Clinical Psychopharmacology. 26(1):79-83, February 2006

Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release: A Double-blind, Randomized Multicenter Trial Comparing the Onset of Antidepressant Response in Patients With Major Depressive Disorder
Benkert, Otto; Szegedi, Armin; Philipp, Michael; Kohnen, Ralf; Heinrich, Claus; Heukels, Anja; van der Vegte-Senden, Monique; Baker, Ross A.; Simmons, John H.; Schutte, Albert-Jan

Journal of Clinical Psychopharmacology. 26(1):75-78, February 2006

New Possibilities of Treatment for Panic Attacks in Elderly Patients: Escitalopram Versus Citalopram
Rampello, Liborio; Alvano, Alessandro; Raffaele, Rocco; Malaguarnera, Mariano; Vecchio, Ignazio

Journal of Clinical Psychopharmacology. 26(1):67-70, February 2006

A Meta-Analysis of Early Sustained Response Rates Between Antidepressants and Placebo for the Treatment of Major Depressive Disorder
Papakostas, George I; Perlis, Roy H.; Scalia, Margaret J.; Petersen, Timothy J.; Fava, Maurizio

Journal of Clinical Psychopharmacology. 26(1):56-60, February 2006

Olanzapine Augmentation in Treatment-Resistant Panic Disorder: A 12-Week, Fixed-Dose, Open-Label Trial
Sepede, Gianna; De Berardis, Domenico; Gambi, Francesco; Campanella, Daniela; La Rovere, Raffaella; D'Amico, Michele; Cicconetti, Alessandra; Penna, Laura; Peca, Silvana; Carano, Alessandro; Mancini, Enrico; Salerno, Rosa Maria; Ferro, Filippo Maria

Journal of Clinical Psychopharmacology. 26(1):45-49, February 2006

Recent developments and current controversies in depression

ProfKlaus P Ebmeier, Claire Donaghey and J Douglas Steele

The Lancet. Volume 367, Issue 9505, 14 January 2006-20 January 2006, Pages 153-167

 

Evidence for three distinct classes of 'typical', 'psychotic' and 'dual' mania: results from the EMBLEM study

J. M. Haro, J. van Os, E. Vieta, C. Reed, M. Lorenzo, I. Goetz and the EMBLEM Advisory Board

Acta Psychiatrica Scandinavica. Volume 113 Page 112  - February 2006

Emerging Treatments for Bipolar Disorder: Safety and Adverse Effect Profiles (CE) (February)
Marken PA, Pies RW

Ann Pharmacother. 2006 Jan 10; [Epub ahead of print]

Combined Total Sleep Deprivation and Light Therapy in the Treatment of Drug-Resistant Bipolar Depression: Acute Response and Long-Term Remission Rates
Benedetti F, Barbini B, Cigala Fulgosi M, Colombo C, Dallaspezia S, Pontiggia A, Smeraldi E

J Clin Psychiatry. 2005 Dec;66(12):1535-1540

Does rTMS Hasten the Response to Escitalopram, Sertraline, or Venlafaxine in Patients With Major Depressive Disorder? A Double-Blind, Randomized, Sham-Controlled Trial
Rossini D, Magri L, Lucca A, Giordani S, Smeraldi E, Zanardi R

J Clin Psychiatry. 2005 Dec;66(12):1569-75

 

The extent of induction of CYP3A by St. John’s wort varies among products and is linked to hyperforin dose

Silke C. Mueller, Jolanta Majcher-Peszynska, Bernhard Uehleke, Sebastian Klammt, Ralf G. Mundkowski, Wolfram Miekisch, Hartwig Sievers, Steffen Bauer, Bruno Frank, Guenther Kundt and Bernd Drewelow

European Journal of Clinical Pharmacology 2006; Volume 62, Number 1: 29 - 36

 

Onset of action of escitalopram compared with other antidepressants: results of a pooled analysis
Kasper, Siegfried; Spadone, Christian; Verpillat, Patrice; Angst, Jules

International Clinical Psychopharmacology. 21(2):105-110, March 2006

Suicide trends in discharged patients with mood disorders: associations with selective serotonin uptake inhibitors and comorbid substance misuse
Fazel, Seena; Grann, Martin; Goodwin, Guy M

International Clinical Psychopharmacology. 21(2):111-115, March 2006

A Controlled Study of Repetitive Transcranial Magnetic Stimulation in Medication-Resistant Major Depression

David H. Avery, Paul E. Holtzheimer III, Walid Fawaz, Joan Russo, John Neumaier, David L. Dunner, David R. Haynor, Keith H. Claypoole, Chandra Wajdik and Peter Roy-Byrne

Biological Psychiatry. Volume 59, Issue 2, 15 January 2006, Pages 187-194

 

Posttraumatic stress disorder: A state-of-the-science review

Charles B. Nemeroff, J. Douglas Bremner, Edna B. Foa, Helen S. Mayberg, Carol S. North and Murray B. Stein

Journal of Psychiatric Research. Volume 40, Issue 1, February 2006, Pages 1-21

 

Detecting psychotic major depression using psychiatric rating scales

Jennifer Keller, Rowena G. Gomez, Heather A. Kenna, Joel Poesner, Charles DeBattista, Benjamin Flores and Alan F. Schatzberg

Journal of Psychiatric Research. Volume 40, Issue 1, February 2006, Pages 22-29

 

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

S.H. Kennedy and R. Emsley

European Neuropsychopharmacology. Volume 16, Issue 2, February 2006, Pages 93-100

 

Antidepressants use in children and adolescents and the risk of suicide

Tamar D. Wohlfarth, Barbara J. van Zwieten, Frits J. Lekkerkerker, Christine C. Gispen-de Wied, Jerry R. Ruis, Andre J.A. Elferink and Jitschak G. Storosum

European Neuropsychopharmacology. Volume 16, Issue 2, February 2006, Pages 79-83

 

Pharmacokinetic-pharmacodynamic modelling of QT interval prolongation following citalopram overdoses
Friberg LE, Isbister GK, Duffull SB

Br J Clin Pharmacol. 2006 Feb;61(2):177-90

Stereoselective disposition of fluoxetine and norfluoxetine during pregnancy and breast-feeding
Kim J, Riggs KW, Misri S, Kent N, Oberlander TF, Grunau RE, Fitzgerald C, Rurak D

Br J Clin Pharmacol. 2006 Feb;61(2):155-63

The pharmacokinetic and pharmacodynamic consequences of the co-administration of lamotrigine and a combined oral contraceptive in healthy female subjects
Sidhu J, Job S, Singh S, Philipson R

Br J Clin Pharmacol. 2006 Feb;61(2):191-9

PERSISTENT TARDIVE REBOUND PANIC DISORDER, REBOUND ANXIETY AND INSOMNIA FOLLOWING PAROXETINE WITHDRAWAL: A REVIEW OF REBOUND-WITHDRAWAL PHENOMENA

Nadeem H Bhanji, Guy Chouinard, Theodore Kolivakis, Howard C Margolese

Can J Clin Pharmacol Vol 13(1) Winter 2006: e69-e74

 

 

The Effects of Alcohol and Drug Dependence on the Course of Depression

Vito Agosti and Frances R. Levin

American Journal on Addictions; Volume 15, Number 1 / 2006: 71 - 75

 

Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment

Lee S. Cohen, Lori L. Altshuler, Bernard L. Harlow, Ruta Nonacs, D. Jeffrey Newport, Adele C. Viguera, Rita Suri, Vivien K. Burt, Victoria Hendrick, Alison M. Reminick, Ada Loughead, Allison F. Vitonis, Zachary N. Stowe

JAMA. 2006;295:499-507

 

.

Regresar a RESÚMENES ENERO 2006